A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2011
05/24/2011	CA2440596C Soluble heterodimeric cytokine receptor
05/24/2011	CA2412947C Method for treating a movement disorder
05/24/2011	CA2402653C Antiseptic coating for the prevention of disease transmission via biofilms
05/24/2011	CA2401604C Method of treating cancer with anti-neurotrophin agents
05/24/2011	CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby
05/24/2011	CA2345201C Mature protein having antagonistic activity against bone morphogenetic protein
05/24/2011	CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
05/24/2011	CA2319310C Equine fc epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and uses thereof
05/24/2011	CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors
05/24/2011	CA2270913C Human tumor necrosis factor receptor-like 2
05/24/2011	CA2266640C Methods for treating an ischemic disorder and improving stroke outcome
05/24/2011	CA2264258C Novel antimicrobial peptide
05/24/2011	CA2247067C Meltrins
05/24/2011	CA2211687C Vascular endothelial growth factor-b
05/24/2011	CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
05/19/2011	WO2011060393A1 Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore
05/19/2011	WO2011060372A2 Factor viii b cell epitope variants having reduced immunogenicity
05/19/2011	WO2011060371A2 Factor viii t cell epitope variants having reduced immunogenicity
05/19/2011	WO2011060355A1 Process for the synthesis of ac-arg-cyclo(cys-d-ala-his-d-phe-arg-trp-cys)-nh2
05/19/2011	WO2011060349A1 Methods of modulating mesenchymal stem cells
05/19/2011	WO2011060333A1 Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2
05/19/2011	WO2011060181A1 Lunasin-containing complex and purification of lunasin from plants
05/19/2011	WO2011060179A1 Use of peptide epoxyketones for metastasis suppression
05/19/2011	WO2011060079A1 Compositions and methods for wound treatment
05/19/2011	WO2011060018A2 Compositions and methods for using peptides, modified peptides, peptidomimetics and fibrin derivatives
05/19/2011	WO2011059758A2 Apls for treating arthritis
05/19/2011	WO2011058982A1 Therapeutic agent for gastrointestinal diseases
05/19/2011	WO2011058557A1 Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
05/19/2011	WO2011058508A2 New compositions for the treatment of chemioresitant and/or potentially chemioresistant leukaemias
05/19/2011	WO2011058449A2 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
05/19/2011	WO2011058286A1 Method for purifying factor b
05/19/2011	WO2011058285A1 Method for manufacturing a factor h preparation
05/19/2011	WO2011058284A1 Preparation of a factor h concentrate
05/19/2011	WO2011058280A1 Human fertility test using dpy19l2
05/19/2011	WO2011058183A1 Par-1 antagonists for use in the treatment or prevention of influenza virus type a infections
05/19/2011	WO2011058182A1 Osteopontin-conditioned medium for the treatment of vascular diseases
05/19/2011	WO2011058165A1 Long-acting y2 receptor agonists
05/19/2011	WO2011058083A1 Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
05/19/2011	WO2011058082A1 Pharmaceutical composition comprising a glp-1 agonist and methionine
05/19/2011	WO2011057805A1 Tubulin inhibitors
05/19/2011	WO2011057504A1 Use of variable lymphocyte receptor (vlr) of agnatha in medicament preparation
05/19/2011	WO2011057397A1 Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions
05/19/2011	WO2011057386A1 Composition and prophylactic device for enhancing sexual performance or pleasure
05/19/2011	WO2011057326A1 Method of treatment of type 2 diabetes
05/19/2011	WO2011038066A3 Novel npr-b agonists
05/19/2011	WO2011036665A3 Leptin for use in increasing liver regeneration
05/19/2011	WO2011035330A3 Oxytocin receptor agonists
05/19/2011	WO2011033391A3 Methods of treating a patient receiving a cardiac stent implant
05/19/2011	WO2011017564A3 Identification and use of compounds for treating persistent pain
05/19/2011	WO2011017502A3 Linaclotide-containing formulations for oral administration
05/19/2011	WO2011007961A3 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitpoes
05/19/2011	WO2011007350A3 Use of nle proteins and tissue - targeted delivery system thereof for the treatment of imune-related disorders
05/19/2011	WO2011006079A3 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using
05/19/2011	WO2011006072A3 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia
05/19/2011	WO2011004260A3 Composition for the treatment of benign prostate hyperplasia
05/19/2011	WO2010151338A3 Myostatin inhibitor enhancement of musculoskeletal repair
05/19/2011	WO2010150082A3 Use of chromogranin a and peptidic derivatives thereof in the treatment of inflammation
05/19/2011	WO2010140060A3 Relaxin peptide synthesis
05/19/2011	WO2010138392A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
05/19/2011	WO2010138384A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
05/19/2011	WO2010138366A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
05/19/2011	WO2010128407A3 Anti-il-17f antibodies and methods of use thereof
05/19/2011	US20110118825 Anti-angiogenic compositions and methods of use
05/19/2011	US20110118456 Interfering RNA Molecules
05/19/2011	US20110118445 Inhibitor protein of the wnt signal pathway
05/19/2011	US20110118335 RNA Interference Mediated Inhibition Of Gene Expression Using Multifunctional Short Interfering Nucleic Acid (Multifunctional siNA)
05/19/2011	US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases
05/19/2011	US20110118195 Methods and Compositions for the Treatment of Gastrointestinal Disorders
05/19/2011	US20110118194 Therapeutic Use of LPI, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory Diseases
05/19/2011	US20110118193 Treatment of liquid cancers
05/19/2011	US20110118192 Methods and compositions for treating t-cell leukemia
05/19/2011	US20110118191 Crotoxin Administration for Cancer Treatment and Pain Relief
05/19/2011	US20110118190 Postsynaptically Targeted Chemodenervation Agents and Their Methods of Use
05/19/2011	US20110118189 Novel formulations for treatment of migraine
05/19/2011	US20110118188 Factor viii polypeptide having factor viii:c activity
05/19/2011	US20110118187 Reversible platelet inhibition
05/19/2011	US20110118186 Synthetic peptide amides and dimeric forms thereof
05/19/2011	US20110118185 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
05/19/2011	US20110118184 Treatments of Gastrointestinal Disorders
05/19/2011	US20110118183 N-glycosylated human growth hormone with prolonged circulatory half-life
05/19/2011	US20110118182 Process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
05/19/2011	US20110118181 Pcsk9 inhibitors and methods of use thereof
05/19/2011	US20110118180 Method of treatment of diabetes type 2 comprising add-on therapy to metformin
05/19/2011	US20110118179 Cation complexes of insulin compound conjugates, formulations and uses thereof
05/19/2011	US20110118178 Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin
05/19/2011	US20110118177 Biotechnological production of cyanophycin dipeptides
05/19/2011	US20110118176 Novel possibility of controlling diseases caused by trichomonadida
05/19/2011	US20110118175 Competitive inhibitors of invariant chain expression and/or ectopic clip binding
05/19/2011	US20110118174 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
05/19/2011	US20110118173 Method of delipidation of hdl using serum opacity factor to prevent, inhibit, and/or reverse atherosclerosis
05/19/2011	US20110118172 Metastin derivative and use thereof
05/19/2011	US20110118171 Process for producing fatty acid and active ingredient extracts, and fatty acids and active ingredients themselves
05/19/2011	US20110117654 Buffer solution for electroporation and a method comprising the use of the same
05/19/2011	US20110117646 Antisense modulation of c-reactive protein expression
05/19/2011	US20110117624 Proteases and variants thereof
05/19/2011	US20110117576 Mct-1, a human oncogene
05/19/2011	US20110117569 Polymide nucleic acid derivatives, and agents and processes for preparing them
05/19/2011	US20110117202 Up and down conversion systems for production of emitted light from various energy sources including radio frequency, microwave energy and magnetic induction sources for upconversion
05/19/2011	US20110117195 Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers
05/19/2011	US20110117194 Pharmaceutical formulation containing angiotensin-ii receptor blocker

1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 3163